Fresenius Medical Care AG & Co. KGaA
· ISIN: DE0005785802
· EQS - adhoc news
Favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million – 2023 earnings outlook raised
Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor
Smart tools for smart investors can be found in our Tools section
Corporate News Fresenius Medical Care AG & Co. KGaA
In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
This might be interesting for you as well
21 November 2023 09:28PM
Favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million – 2023 earnings outlook raised
Bad Homburg, November 21, 2023 | Fresenius Medical Care AG & Co. KGaA (the “Company”) through its subsidiary Fresenius Medical Care Holdings, Inc. (“FMCH”) resolved a legal dispute with the U.S. government, for accounts receivable in legal dispute, and entered into a final and legally binding settlement agreement today, whereby the Company will...
Fresenius Medical Care AG & Co. KGaA
01 November 2023 08:59PM
Fresenius Medical Care AG & Co. KGaA raises outlook for operating income in fiscal year 2023
Bad Homburg, November 1, 2023 | Fresenius Medical Care AG & Co. KGaA ("Fresenius Medical Care” or the "Company") has decided today, to raise the outlook for operating income in fiscal year 2023. The background to the decision are the positive effects of the turnaround measures and the accelerated improvements in operational performance in the f...
Fresenius Medical Care AG & Co. KGaA
21 February 2023 07:05PM
Fresenius Medical Care AG & Co. KGaA initiates firm plans for change of the legal form into a German stock corporation
Bad Homburg, 21 February 2023. The Supervisory Board of Fresenius Medical Care Management AG has today approved the Management Board’s resolution to initiate firm plans for a change of the legal form of Fresenius Medical Care AG & Co. KGaA (the "Company") from a partnership limited by shares (Kommanditgesellgesellschaft auf Aktien – KGaA) into ...
Fresenius Medical Care AG & Co. KGaA
21 February 2023 07:05PM
Fresenius Medical Care AG & Co. KGaA initiates firm plans for change of the legal form into a German stock corporation
Bad Homburg, 21 February 2023. The Supervisory Board of Fresenius Medical Care Management AG has today approved the Management Board’s resolution to initiate firm plans for a change of the legal form of Fresenius Medical Care AG & Co. KGaA (the "Company") from a partnership limited by shares (Kommanditgesellgesellschaft auf Aktien – KGaA) into ...
Fresenius Medical Care AG & Co. KGaA
09 February 2023 04:26PM
Fresenius Medical Care AG & Co. KGaA confirms review of the deconsolidation and a potential change of the legal form into a German stock corporation
Bad Homburg, February 9, 2023
Following press reports, Fresenius Medical Care AG & Co. KGaA (“Company”) confirms that Fresenius SE & Co. KGaA, which is holding approx. 32% of the shares of the Company and which is the sole shareholder of the general partner Fresenius Medical Care Management AG, is reviewing the deconsolidation of the Compan...
Fresenius Medical Care AG & Co. KGaA
09 February 2023 04:26PM
Fresenius Medical Care AG & Co. KGaA confirms review of the deconsolidation and a potential change of the legal form into a German stock corporation
Bad Homburg, February 9, 2023
Following press reports, Fresenius Medical Care AG & Co. KGaA (“Company”) confirms that Fresenius SE & Co. KGaA, which is holding approx. 32% of the shares of the Company and which is the sole shareholder of the general partner Fresenius Medical Care Management AG, is reviewing the deconsolidation of the Compan...
Fresenius Medical Care AG & Co. KGaA
05 December 2022 11:39PM
Fresenius Medical Care AG & Co. KGaA: Helen Giza to take over as Chief Executive Officer of Fresenius Medical Care
Helen Giza (54) has been appointed Chief Executive Officer of Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, with immediate effect. Previously, she was Deputy CEO of Fresenius Medical Care. The Supervisory Board of Fresenius Medical Care Management AG unanimously appointed her to s...
Fresenius Medical Care AG & Co. KGaA
05 December 2022 11:39PM
Helen Giza to take over as Chief Executive Officer of Fresenius Medical Care
Helen Giza (54) has been appointed Chief Executive Officer of Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, with immediate effect. Previously, she was Deputy CEO of Fresenius Medical Care. The Supervisory Board of Fresenius Medical Care Management AG unanimously appointed her to s...
Fresenius Medical Care AG & Co. KGaA
05 December 2022 11:34PM
Ms. Helen Giza appointed as new CEO of the Management Board; Dr. Carla Kriwet agreed to resign as CEO and member of the Management Board
Today, the Supervisory Board of Fresenius Medical Care Management AG, the General Partner of Fresenius Medical Care AG & Co. KGaA, has unanimously appointed Ms. Helen Giza as CEO of the Management Board with effect as of the beginning of December 6, 2022. Ms. Helen Giza remains also acting Chief Financial Officer of Fresenius Medical Care until...
Fresenius Medical Care AG & Co. KGaA
05 December 2022 11:34PM
Fresenius Medical Care AG & Co. KGaA: Ms. Helen Giza appointed as new CEO of the Management Board; Dr. Carla Kriwet agreed to resign as CEO and member of the Management Board
Today, the Supervisory Board of Fresenius Medical Care Management AG, the General Partner of Fresenius Medical Care AG & Co. KGaA, has unanimously appointed Ms. Helen Giza as CEO of the Management Board with effect as of the beginning of December 6, 2022. Ms. Helen Giza remains also acting Chief Financial Officer of Fresenius Medical Care until...
Fresenius Medical Care AG & Co. KGaA
30 October 2022 05:35PM
Fresenius Medical Care AG & Co. KGaA revises financial outlook for full year 2022
Fresenius Medical Care revises financial outlook for full year 2022 due to delayed effects from improvements in North American Services business in challenging environment
Business development continues to be strongly impacted by highly uncertain macroeconomic environment driving wage and general cost inflation in all reporting segments
Im...
Fresenius Medical Care AG & Co. KGaA
30 October 2022 05:35PM
Fresenius Medical Care AG & Co. KGaA revises financial outlook for full year 2022
Fresenius Medical Care revises financial outlook for full year 2022 due to delayed effects from improvements in North American Services business in challenging environment
Business development continues to be strongly impacted by highly uncertain macroeconomic environment driving wage and general cost inflation in all reporting segments
Im...
Fresenius Medical Care AG & Co. KGaA
30 October 2022 05:30PM
Fresenius Medical Care AG & Co. KGaA extends net income target range for financial year 2022
Since Fresenius Medical Care continues to operate in a challenging environment, the impacts of the Company’s focused efforts to improve North American Health Care Services operations are delayed against previous assumptions. Therefore, Fresenius Medical Care now assumes lower contributions in the financial year 2022.
Consequently, Fresenius Medica...
Fresenius Medical Care AG & Co. KGaA
30 October 2022 05:30PM
Fresenius Medical Care AG & Co. KGaA extends net income target range for financial year 2022
Since Fresenius Medical Care continues to operate in a challenging environment, the impacts of the Company’s focused efforts to improve North American Health Care Services operations are delayed against previous assumptions. Therefore, Fresenius Medical Care now assumes lower contributions in the financial year 2022.
Consequently, Fresenius Medica...
Fresenius Medical Care AG & Co. KGaA
27 July 2022 10:38PM
Fresenius Medical Care AG & Co. KGaA cuts outlook for FY 2022 due to increased headwinds from U.S. labor market situation and global inflation, and withdraws 2025 targets
In the second quarter Fresenius Medical Care experienced increasing different headwinds that are now expected to negatively impact the Company´s earnings development in the second half of FY 2022 to a significant larger degree than anticipated when giving guidance. Earnings development in particular is anticipated to be affected by increased wage i...
Fresenius Medical Care AG & Co. KGaA
27 July 2022 10:38PM
Fresenius Medical Care AG & Co. KGaA cuts outlook for FY 2022 due to increased headwinds from U.S. labor market situation and global inflation, and withdraws 2025 targets
In the second quarter Fresenius Medical Care experienced increasing different headwinds that are now expected to negatively impact the Company´s earnings development in the second half of FY 2022 to a significant larger degree than anticipated when giving guidance. Earnings development in particular is anticipated to be affected by increased wage i...
Fresenius Medical Care AG & Co. KGaA
04 May 2022 07:08AM
Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care reports first quarter results in line with its expectations despite significant headwinds
- Higher than anticipated COVID-19-related excess mortality, but declining throughout the quarter
- Earnings development affected by ongoing significantly elevated labor costs compounded by effects from Omicron in Health Care Services and by increased material and logistics costs in Health Care Products
- Earnings development in EMEA additionally...
Fresenius Medical Care AG & Co. KGaA
03 May 2022 10:21PM
Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet to succeed Rice Powell as Chief Executive Officer of Fresenius Medical Care
Dr. Carla Kriwet (51) will become the new CEO of Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, on January 1, 2023. The Supervisory Board of Fresenius Medical Care Management AG unanimously appointed her to succeed Rice Powell (66), who in accordance with the company’s age limit fo...
Fresenius Medical Care AG & Co. KGaA
03 May 2022 10:12PM
Fresenius Medical Care AG & Co. KGaA: Dr. Carla Kriwet succeeds Rice Powell as CEO of the Management Board of Fresenius Medical Care
In today’s meeting the Supervisory Board of Fresenius Medical Care's General Partner unanimously appointed Dr. Carla Kriwet as CEO of the Management Board effective January 1, 2023. Dr. Carla Kriwet succeeds Rice Powell, who will step down from the Management Board in light of the age limit for members of the Management Board when his contract expi...
Fresenius Medical Care AG & Co. KGaA
21 March 2022 02:00PM
Fresenius Medical Care participates in three-way merger to create premier value-based kidney care provider in the U.S. - next important step in execution of growth strategy 2025
- Creation of new company combines strengths of three leading value-based care specialists
- Execution on strategic expansion along the renal care continuum significantly expands Fresenius Medical Care's total addressable market in the U.S. from around $50 billion to around $170 billion
- Establishing independent and integrated value-based care off...
Fresenius Medical Care AG & Co. KGaA
23 February 2022 10:30AM
Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care published form 20-F for the fiscal year 2021
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, has filed the annual report 2021 on form 20-F with the U.S. Securities and Exchange Commission (SEC). The report is available at the company's website (freseniusmedicalcare.com) in the "Investors" section as well as at the SEC's websit...
Fresenius Medical Care AG & Co. KGaA
22 February 2022 07:16AM
Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care sets climate targets: Climate neutrality by 2040, CO2 emissions to fall 50% by 2030
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, commits to become climate neutral by 2040. This applies both to direct and indirect CO2 emissions (Scope 1 and 2) - also in view of the expected future business growth. The company is also continuously assessing its emissions across th...
Fresenius Medical Care AG & Co. KGaA
22 February 2022 07:02AM
Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care delivers on 2021 guidance, targets return to earnings growth in 2022
- Business development significantly impacted by COVID-19 in 2021, effects are expected to continue into 2022
- Decline in excess mortality in the fourth quarter
- 25th consecutive dividend increase to 1.35 EUR proposed
- Implementation of strategic priorities on track
Rice Powell, Chief Executive Officer of Fresenius Medical Care, said: "Througho...
Fresenius Medical Care AG & Co. KGaA
01 December 2021 08:30AM
Fresenius Medical Care AG & Co. KGaA announces changes to Management Board, reflecting the transformation to the company's new operating model
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced changes to the Management Board effective on January 1, 2022. They follow a unanimous decision by the Supervisory Board of Fresenius Medical Care Management AG to adapt the composition of the Management Board to the com...
Fresenius Medical Care AG & Co. KGaA
02 November 2021 07:11AM
Fresenius Medical Care AG & Co. KGaA confirms outlook for 2021 while considering the continued negative impact of COVID-19
Stronger than projected headwind from COVID-19 effects with significantly increased patient excess mortality due to global spread of Delta variant
Organic growth continued with 1%
Financial targets for FY 2021 confirmed, expectation to reach lower end of the guidance ranges for revenue and net income
FME25 transformation update to achieve EUR ...
Fresenius Medical Care AG & Co. KGaA
02 November 2021 06:52AM
Fresenius Medical Care AG & Co. KGaA transforms its operating model, entering the next phase of its 2025 growth strategy
Globalization of operating model to leverage expertise, capture growth opportunities and accelerate value creation
Business operations to be structured in two global operating segments: Care Enablement and Care Delivery
Reduction of annual cost base of EUR 500 million by 2025 with anticipated one-time investments of around EUR 450-500 million
Fi...
Fresenius Medical Care AG & Co. KGaA
30 July 2021 07:03AM
Fresenius Medical Care AG & Co. KGaA reports results in line with expectations for the second quarter and confirms 2021 outlook
As assumed, COVID-19 pandemic continued to impact organic growth in dialysis and downstream businesses
Patient excess mortality rates significantly reduced
Negative exchange rate effects continue
Earnings development impacted by phasing and strong prior-year base, as indicated
Financial targets for FY 2021 confirmed
FME25 program on track
Rice...
Fresenius Medical Care AG & Co. KGaA
06 May 2021 07:08AM
Fresenius Medical Care delivers solid first quarter in light of the COVID-19 pandemic, confirms outlook for 2021
May 6, 2021
Fresenius Medical Care delivers solid first quarter in light of the COVID-19 pandemic, confirms outlook for 2021
- Organic treatment growth impacted by COVID-19 pandemic as expected
- Reported revenue and earnings continued to be adversely affected by exchange rate effects
- Earnings development supported by phasing and expected low...
Fresenius Medical Care AG & Co. KGaA
06 May 2021 07:05AM
Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care delivers solid first quarter in light of the COVID-19 pandemic, confirms outlook for 2021
- Organic treatment growth impacted by COVID-19 pandemic as expected
- Reported revenue and earnings continued to be adversely affected by exchange rate effects
- Earnings development supported by phasing and expected lower SG&A expense anticipated to reverse throughout the year
- Vaccination of patients accelerated to 51 percent globally
- Fin...
Fresenius Medical Care AG & Co. KGaA
29 October 2020 07:03AM
Fresenius Medical Care AG & Co. KGaA continues solid revenue and strong earnings growth in the third quarter
- Operations maintained despite COVID-19, impact on patients minimized
- Q3 development impacted by currency headwinds and expected lower reimbursement for calcimimetics
- Financial targets for FY 2020 confirmed inclusive of anticipated COVID-19 effects
"The global COVID-19 pandemic has posed further challenges to us in the third quarter; and it...
Fresenius Medical Care AG & Co. KGaA
30 July 2020 07:05AM
Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care delivers very strong second quarter results
- Solid revenue growth continued
- Significant net income growth
- Exceptionally positive free cash flow development
- Financial targets for FY2020 confirmed inclusive of anticipated COVID-19 effects
Rice Powell, Chief Executive Officer of Fresenius Medical Care, said: "As anticipated, we saw the COVID-19 pandemic spread globally in the second quar...
Fresenius Medical Care AG & Co. KGaA
More Fresenius Medical Care AG & Co. KGaA related information
| Type | Total | Last | Made by | Go to |
|---|---|---|---|---|
| Corporate Research | 0 | - | - | Corporate Research |
| Directors Dealings | 30 | 20th March 2024 | Giza, Helen Pring | DD |
| Short Seller (DE) | 11 | 14th May 2024 | Kintbury Capital LLP | SSR (DE) |
| Short Seller (UK) | 0 | - | - | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.
v.07062023 EN